Dual vs. triple therapy for childhood Helicobacter pylori gastritis:: a double-blind randomized multicentre trial

被引:27
作者
Oderda, G
Marinello, D
Lerro, P
Kuvidi, M
de'Angelis, GL
Ferzetti, A
Cucchiara, S
Franco, MT
Romano, C
Strisciuglio, P
Pensabene, L
机构
[1] Univ Novara, Dept Pediat, Novara, Italy
[2] Univ Turin, Dept Pediat, I-10124 Turin, Italy
[3] Univ Parma, Dept Pediat, I-43100 Parma, Italy
[4] Univ Naples Federico II, Dept Pediat, I-80138 Naples, Italy
[5] Univ Reggio Calabria, Dept Pediat, Reggio Di Calabria, Italy
[6] Univ Catanzaro, Dept Pediat, Catanzaro, Italy
关键词
Helicobacter pylori; childhood gastritis; triple therapy; dual therapy; double blind trial; dyspepsia; epigastric pain; clinica pediatrica;
D O I
10.1111/j.1083-4389.2004.00242.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Data on the efficacy of eradication treatment for Helicobacter pylori gastritis in children are scarce. Aim. To evaluate the efficacy of triple therapy with lansoprazole plus amoxicillin and tinidazole vs. dual therapy with amoxicillin and tinidazole in a double-blind randomized multicentre trial, and the usefulness of eradication in terms of long-term symptom resolution. Subjects. We enrolled 43 consecutive children undergoing endoscopy for upper gastrointestinal dyspepsia with H. pylori gastritis. They underwent a C-13-urea breath test, completed a 2-week symptom diary card, and were randomized. Treatment was given in a Redidose box (Redidose Company Ltd., Brighton, UK) containing either lansoprazole-amoxicillin-tinidazole (triple therapy) or placebo plus amoxicillin-tinidazole (dual therapy) for 1 week. The completion of a 2-week symptom diary card and the performance of a breath test were repeated 6 weeks and 6 months after the end of therapy. One to two years later, a structured telephone interview was conducted with 36 of the children. Results. According to the breath test, 6 weeks after the end of therapy H. pylori was eradicated in 15 of 22 children on triple therapy [68.2%; 95% confidence interval (CI) = 45-88] and in 15 of 21 children on dual therapy (71%; 95% CI = 48-89; not significant), and 6 months after the end of therapy it was eradicated in 16 of 22 children on triple therapy (72.7%) and in 15 of 21 children on dual therapy. Six months after therapy, symptoms were analysed in 11 H. pylori-positive and 31 H. pylori-negative children, and it was found that dyspeptic symptoms had disappeared or improved in both groups, with no difference between them. One to two years later, 36 children were interviewed. Epigastric pain had recurred in three of 26 H. pylori-negative and in seven of 10 H. pylori-positive children (p = .001); in three of the latter, pain was severe and required additional treatment. Conclusion. One-week triple or dual therapy with two antibiotics achieved similar eradication rates. Soon after treatment, symptoms disappeared or improved in most children irrespective of eradication, but epigastric pain recurred in the majority of the still-infected children within 2 years.
引用
收藏
页码:293 / 301
页数:9
相关论文
共 32 条
[1]   The HOMER study:: The effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection [J].
Bardhan, KD ;
Bayerdörffer, E ;
Van Zanten, SJOV ;
Lind, T ;
Mégraud, F ;
Delchier, JC ;
Hellblom, M ;
Stubberöd, A ;
Burman, CF ;
Gromark, PO ;
Zeijlon, L .
HELICOBACTER, 2000, 5 (04) :196-201
[2]  
Bazzoli F, 2000, AM J GASTROENTEROL, V95, P646, DOI 10.1111/j.1572-0241.2000.01836.x
[3]  
Chong SKF, 2003, AM J GASTROENTEROL, V98, P2162, DOI [10.1016/S0002-9270(03)00668-3, 10.1111/j.1572-0241.2003.07683.x]
[4]  
Cucchiara S, 1996, ITAL J GASTROENTEROL, V28, P430
[5]   Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis? [J].
de Boer, WA ;
Tytgat, GNJ .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (11) :1281-1284
[6]   A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents [J].
De Giacomo, C ;
Valdambrini, V ;
Lizzoli, F ;
Gissi, A ;
Palestra, M ;
Tinelli, C ;
Zagari, M ;
Bazzoli, F .
HELICOBACTER, 2002, 7 (06) :356-363
[7]  
Drumm Brendan, 2000, JPGN, V30, P207, DOI 10.1097/00005176-200002000-00020
[8]   Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood [J].
Franco, MT ;
Salvia, G ;
Terrin, G ;
Spadaro, R ;
De Rosa, I ;
Iula, VD ;
Cucchiara, S .
DIGESTIVE AND LIVER DISEASE, 2000, 32 (08) :660-666
[9]   Helicobacter pylori infection in children:: Recommendations for diagnosis and treatment [J].
Gold, BD ;
Colletti, RB ;
Abbott, M ;
Czinn, SJ ;
Elitsur, Y ;
Hassall, E ;
Macarthur, C ;
Snyder, J ;
Sherman, PM .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 31 (05) :490-497
[10]   Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis:: A prospective randomized double-blind trial [J].
Gottrand, F ;
Kalach, N ;
Spyckerelle, C ;
Guimber, D ;
Mougenot, JF ;
Tounian, P ;
Lenaerts, C ;
Roquelaure, B ;
Lachaux, A ;
Morali, A ;
Dupont, C ;
Maurage, C ;
Husson, MO ;
Barthelemy, P .
JOURNAL OF PEDIATRICS, 2001, 139 (05) :664-668